Maternal anesthesia and analgesia affecting fetus or newborn

This code identifies adverse effects experienced by a fetus or newborn due to medications administered to the mother for anesthesia or analgesia during labor and delivery. These effects can range from respiratory depression and hypotonia to altered neurological status in the neonate. It specifically points to a causal link between maternal medication and neonatal compromise.

Use this code when documentation clearly indicates that maternal anesthesia or analgesic agents administered during childbirth are directly implicated in an adverse outcome for the neonate. This often includes scenarios where the newborn exhibits signs of drug-induced depression, such as low Apgar scores, requiring resuscitation or extended observation. Documentation should specify the maternal medication and the resulting neonatal condition.

• Always sequence this code after the primary diagnosis describing the specific neonatal condition (e.g., neonatal respiratory depression).
• Ensure documentation explicitly links the maternal medication to the neonatal effect; avoid assumptions.
• Do not use this code for adverse effects solely attributable to the delivery process itself or other neonatal conditions unrelated to maternal medication.